A new project aims to help doctors predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best-targeted treatment before it spreads. A new £1.5 million research project harnessing artificial intelligence (AI)
Artificial Intelligence reveals prostate cancer is not just one disease
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future. A Cancer Research UK-funded study, published in Cell Genomics, reveals that prostate cancer, which affects one in
TRANSFORM trial
“The £42 million TRANSFORM trial, the biggest prostate cancer screening trial in 20 years, could save the lives of thousands of men each year.” – Prostate Cancer UK Prostate Cancer UK is launching this new initiative – the TRANSFORM trial
ICR Donation
Cancer Research & Genetics UK are donating £10000 to Professor Eeles research at the ICR. “We, at The Institute of Cancer Research, London, are extremely grateful for the generous donation from Cancer Research and Genetics UK to sponsor the maintenance
Liverpool University Donation
The University of Liverpool has received another £10,000 donation from Cancer Charity, Cancer Research and Genetics UK (CRGUK), further securing the long-standing partnership which has seen the CRGUK donate over £70,000 to the University to help fund vital cancer research.
Cardiff University Donation
Donation to colorectal cancer at Cardiff University Cancer Research and Genetics UK’s generous £10,000 donation to Cardiff University will be used to fund a Nano Photometer Spectrophotometer and two freezers for Matthew McKenna’s research project into treatments for colorectal cancer.
Liverpool Update – Cancer Research Genetics UK Oct ’23
Translation Immunology Group We hope you enjoy reading this update report on your generous donation to the Translational Immunology Group at the University of Liverpool, part of the Department of Molecular and Clinical Cancer Medicine Institute of Systems, Molecular and
Bowel Screening Age Lowered To 51 In Wales
Finally, the Welsh Government and the Health Service are going to honour their 2008 pledge that Bowel Screening roll out for the 50-74 years age group would be rolled out over 5 years. We have had many excuses from the lack of
Imperial partners in UK’s first total-body PET platform for drug discovery
Imperial researchers are partners in a UK initiative to improve clinical imaging for research and the development of new treatments. Scientists at Imperial College London are among a UK-wide team of experts set to lead a new national clinical imaging
Human Cell Expression Facility
Researchers Dr Aaron Wall and Dr Bruce MacLachlan, who’s project CR&GUK generously supported, explain how the donation helps with their work. The equipment is up and running and enabling researchers to progress with their research. In the video, Aaron and
Supporting Cancer Research Equipment Donation
The University of Liverpool is most grateful to Cancer Research and Genetics UK and their supporters for the enormous generosity in supporting our research needs over the years. The recent donation to the Translational Immunology Group in the Department of
Institute of Cancer Research
28/3/23 Cancer Research & Genetics UK are donating £10,000 to the work of Professor Ross Eeles at the Institute of Cancer Research in London on the 28 March 2023.
Proposal for Cancer Research and Genetics UK
Understanding the genetic causes of prostate cancer June 2022 We are enormously grateful for the generosity of Cancer Research and Genetics UK over the years in supporting The Institute of Cancer Research’s (ICR) prostate cancer research. We hope you will
Mama Dear by O’Reily
“After a chance meeting with Mr Nick Philips, the director of the charity, I played him the demo of the song “Mama Dear” and Nick immediately agreed that the song could help his charity. He suggested we record the track
Donation to Liverpool University
15/02/23 Liverpool University Cancer Research & Genetics UK have donated £10,000 to Liverpool University to fund much needed research.
Donation to Imperial University
17/01/23 Imperial University, London Cancer Research & Genetics UK have donated £10,000 to Imperial University, London to purchase a histology slide screen. “Our mission is to ensure all men have access to fast and accurate diagnosis of prostate disease. We
Donation to Cardiff University
6/12/22 University of Cardiff Early career stage researchers, Dr Aaron Wall and Dr Bruce MacLachlan (they work under Prof. Awen Gallimore who we have previously supported and Prof. Andrew Godkin) are looking at how the immune system detects and interacts
Ottensmeier Group
1/7/21 University of Liverpool – Ottensmeier Group The University of Liverpool and local NHS partners recently invested in a major new programme of immunology cancer research to help translate new discoveries into novel treatments for patients as quickly as possible.
Beaston Pebble Appeal
28/6/21 Beaston Pebble Appeal An example of the ground-breaking research taking place at Glasgow includes the work taking place in The Cagan Laboratory. They are investigating and developing new cancer treatments using a classical tool, the fruit fly, Drosophila. The
INCISE project
28/6/21 INCISE project and purchase of two high specification GPU cards Computational workstations to enable deep learning-based bowel cancer screening in the University of Glasgow Digital Pathology Research Centre We are delighted with the support from Cancer Research and Genetics
Chemiluminescence system
31/05/21 Chemiluminescence system for the Division of Cancer and Genetics at Cardiff University Your generous donation will be used to purchase a chemiluminescence system for the Division of Cancer and Genetics at Cardiff University. Chemiluminescence is an analytical imaging technique
Institute of Cancer Research
31/05/21 Institute of Cancer Research As part of their ongoing research Professor Ros Eeles’ work required a centrifuge. In addition to previous donations Cancer Research Genetics UK were delighted to be able to help with a donation of £10,000. The
Clatterbridge Cancer Centre
01/07/20 Cancer Research & Genetics UK have donated £10,000 to the Clatterbridge Cancer Centre at the new Liverpool hospital to buy -86 C freezers for storing tissue samples of patients in cancer research. The work we are supporting will be
Donation to Cardiff University
27/03/20 Cancer Research & Genetics UK have donated £10k to Professor Andrew Sewell’s work at Cardiff University. His research group is focused on T-cell antigens and the receptors that recognise them. Cancer Research and Genetics UK?s donation will purchase a
Liverpool Cancer Hospital
24/12/19 Cancer Research & Genetics UK are in negotiations to buy £10k of equipment for the new Liverpool Cancer Hospital / Clatterbridge Cancer Centre.
Marcia Phillips Tissue Culture Suite
25/8/19 Video of Dr Helen Pearson explaining the impact of the vibratome, funded by Cancer Research and Genetics UK, which sits in the Marcia Phillips Tissue Culture Suite in the European Cancer Stem Cell Research Institute.
Manchester Cancer Centre
16/4/19 Cancer Research & Genetics UK donated £10,000 to the Manchester Cancer Research Centre who work closely with the Christie NHS Foundation Trust, the largest cancer hospital in Europe. To read our latest communications with the university please click here and
Manchester University
20/3/19 One year ago Cancer Research & Genetics UK donated £10,000 to Manchester University to purchase a gentleMACS dissociator. The University has recently got back to us with an update on the progress made in prostate cancer care and research.
Cardiff University
22/2/19 This important donation from Cancer Research & Genetics UK will help support our preclinical studies, investigating how we can improve the efficacy of targeted therapeutic agents to treat prostate cancer and advance our understanding of how this disease develops
Donations
12/2/19 Support from Cancer Research & Genetics UK in 2018 has now been used to purchase an embedding machine for the immunohistochemistry facility, which is currently in development. The Institute would like to thank Cancer Research Genetics UK for their